MarketInOut Stock Screener Log In | Sign Up

Akeso Inc

OTC • Healthcare • Biotechnology • Quote as of 11/18/2026 10:01
Akeso Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization9,689.07 mln
Float731 mln
Earnings Date02/27/2027

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.65
Likely manipulated

Relative Strength

12 / 100
Significantly lagging

Debt / Equity

0.59
Moderate leverage

Pre-Tax Margin

-22%
Deeply loss-making

ROE

-8.93
Negative

Business Description

Akeso Inc. is a China-based biopharmaceutical company founded in 2012 that creates and sells antibody-based medicines for patients around the world. Its pipeline spans a wide range of serious conditions, including multiple forms of cancer such as lung, cervical, gastric, and liver cancer, as well as skin and blood disorders like psoriasis and leukemia. The company has several treatments already on the market and many more in active development, with a particular focus on next-generation bi-specific antibodies that target two disease pathways at once.

Key Fundamentals

EPS-0.15
ROE-8.93
ROIC-13.19
ROA-4.71
EBITDA, mln-45.06
EV / EBITDA-214
EV / EBIT-109
Revenue, mln494
EV / Revenue19.47

Quote Details

Last 7.6000
Change -0.25 (-3.18%)
Open 7.7000
Volume 1,200
Turnover 9,120
Average Volume 4,278.86

Financial Ratios

Pre-Tax Profit Margin-22
Current Ratio4.01
Price / Book7.99
Price / Tangible Book8.02
Debt / Equity0.59
Price / Sales20.24

Financial Strength

Altman Z-Score6.54
Piotroski F-Score 2 / 9
Beneish M-Score-1.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -33.62% 3 / 100   
1 Month -36.67% 8 / 100   
2 Months -39.93% 22 / 100   
6 Months -40.62% 25 / 100   
1 Year -45.69% 26 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog